B. Riley Securities Reiterates Buy on PDS Biotechnology, Lowers Price Target to $11

PDS BIOTECHNOLOGY CORPORATION -1.28% Post

PDS BIOTECHNOLOGY CORPORATION

PDSB

3.08

3.08

-1.28%

0.00% Post

B. Riley Securities analyst Kalpit Patel reiterates PDS Biotechnology (NASDAQ: PDSB) with a Buy and lowers the price target from $14 to $11.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via